199 related articles for article (PubMed ID: 1314448)
1. Expression of the epidermal growth factor receptor in astrocytic tumours is specifically associated with glioblastoma multiforme.
Agosti RM; Leuthold M; Gullick WJ; Yasargil MG; Wiestler OD
Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):321-5. PubMed ID: 1314448
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW
J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical Expression of Epidermal Growth Factor Receptor in Astrocytic Tumors in Iraqi Patients.
Abdulghani MM; Abbas MN; Mohammed WR
Open Access Maced J Med Sci; 2019 Nov; 7(21):3514-3520. PubMed ID: 32010368
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor and proliferating cell nuclear antigen in astrocytomas.
Maiti AK; Ghosh K; Chatterjee U; Chakrobarti S; Chatterjee S; Basu S
Neurol India; 2008; 56(4):456-62. PubMed ID: 19127042
[TBL] [Abstract][Full Text] [Related]
5. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumors given definitive irradiation.
Zhu A; Shaeffer J; Leslie S; Kolm P; El-Mahdi AM
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):809-15. PubMed ID: 8598357
[TBL] [Abstract][Full Text] [Related]
7. Reverse transcriptase polymerase chain reaction as a reliable method to detect epidermal growth factor receptor exon 2-7 gene deletion in human glioblastomas.
Worm K; Dabbagh P; Schwechheimer K
Hum Pathol; 1999 Feb; 30(2):222-7. PubMed ID: 10029453
[TBL] [Abstract][Full Text] [Related]
8. Amplification and differential expression of members of the erbB-gene family in human glioblastoma.
Schlegel J; Stumm G; Brändle K; Merdes A; Mechtersheimer G; Hynes NE; Kiessling M
J Neurooncol; 1994; 22(3):201-7. PubMed ID: 7760096
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989
[TBL] [Abstract][Full Text] [Related]
10. Expression of neu/c-erbB-2 in human brain tumors.
Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
[TBL] [Abstract][Full Text] [Related]
11. The role of immunohistochemistry in predicting behavior of astrocytic tumors.
Ambroise MM; Khosla C; Ghosh M; Mallikarjuna VS; Annapurneswari S
Asian Pac J Cancer Prev; 2010; 11(4):1079-84. PubMed ID: 21133628
[TBL] [Abstract][Full Text] [Related]
12. Expression of the p53 protein in a spectrum of astrocytic tumours.
Ellison DW; Gatter KC; Steart PV; Lane DP; Weller RO
J Pathol; 1992 Dec; 168(4):383-6. PubMed ID: 1336544
[TBL] [Abstract][Full Text] [Related]
13. Proliferative index in astrocytic tumours.
Rathi KR; Radotra BD; Khosla VK
Indian J Pathol Microbiol; 2007 Oct; 50(4):754-8. PubMed ID: 18306542
[TBL] [Abstract][Full Text] [Related]
14. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.
Feldkamp MM; Lala P; Lau N; Roncari L; Guha A
Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas.
Kunkel P; Müller S; Schirmacher P; Stavrou D; Fillbrandt R; Westphal M; Lamszus K
Neuro Oncol; 2001 Apr; 3(2):82-8. PubMed ID: 11296484
[TBL] [Abstract][Full Text] [Related]
16. Concurrent EGFR amplification and TP-53 mutation in glioblastomas.
Gil-Benso R; Lopez-Gines C; Benito R; López-Guerrero JA; Callaghan RC; Pellín A; Roldán P; Cerdá-Nicolas M
Clin Neuropathol; 2007; 26(5):224-31. PubMed ID: 17907599
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.
Liu L; Bäcklund LM; Nilsson BR; Grandér D; Ichimura K; Goike HM; Collins VP
J Mol Med (Berl); 2005 Nov; 83(11):917-26. PubMed ID: 16133418
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway.
Das A; Tan WL; Teo J; Smith DR
J Neurooncol; 2002 Nov; 60(2):117-25. PubMed ID: 12635658
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the erbB gene family calmodulin-binding and calmodulin-like domains in astrocytic gliomas.
Arjona D; Bello MJ; Alonso ME; Gonzalez-Gomez P; Lomas J; Aminoso C; Lopez-Marin I; Isla A; De Campos JM; Vaquero J; Gutierrez M; Villalobo A; Rey JA
Int J Oncol; 2004 Nov; 25(5):1489-94. PubMed ID: 15492843
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor receptors and c-erbB-2 proteins in human astrocytic tumors.
Hwang SL; Chai CY; Lin HJ; Howng SL
Kaohsiung J Med Sci; 1997 Jul; 13(7):417-24. PubMed ID: 9260461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
